Global health review
A weekly round-up of all the latest global health research from MSF projects and beyond
12 July 2024
MSF Scientific Day - Asia 2024 has extended the deadline for abstract submission to 19th June! For guidelines and submission instructions, please visit their website.
This week, in Cochrane Database of Systematic Reviews, Epicentre and MSF researchers compared two antipsychotic medications for use in humanitarian settings with limited resources. The authors expressed uncertainty regarding the difference in benefits between the two options and recommended that practitioners consider the side effects and preferences of patients. In The American Journal of Tropical Medicine and Hygiene, DNDi contributed to a systematic review of efficacy studies for visceral leishmaniasis, emphasising the significant variability in design, conduct, analysis, and reporting across all the studies reviewed.
New England Journal of Medicine has released part 1 of their podcast series focusing on race-based diagnosis to examine how beliefs about race influence medicine and are perceived as scientific. And Transactions of the Royal Society of Tropical Medicine & Hygiene highlighted the need for species-specific antivenom to better manage snakebite.
A correspondence piece in The Lancet warned that the death toll in Gaza might be three to 15 times what has been reported due to the indirect health implications beyond the direct harm from violence. This number of deaths roughly equates to 7.9% of the total population. Finally, the same journal reported on MSF’s decision to replace the MSF Access Campaign with a new structure.
Best regards
Mohammad Salaymeh, Lydia Lampiri, Ononna Thuli and Holly Baker with MSF-authored article assistance from Patricia Kahn and Camryn Lewis.
All MSF-authored publications can be found on the MSF Science Portal, as well as recordings, abstracts and posters from the MSF Scientific Days International 2023 conference.